This is a news story, published by MSN, that relates primarily to Monjaro news.
For more Monjaro news, you can click here:
more Monjaro newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from MSN, you can click here:
more news from MSNOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Lily. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest bullish outlook news, preliminary results news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
obesity pipelineCNBC
•Health
Health
65% Informative
Lily jumped over 3% after reporting an earnings beaten guidance that came in in line with investor expectations.
Revenue for the December quarter did fall short though, with sales of weight loss drugs Monjaro and Zepbound missing estimates for the second straight quarter .
Still, the company giving a bullish outlook for its obesity pipeline moving up the timeline for data on its next Gen. injectable Reddit true tide.
VR Score
61
Informative language
56
Neutral language
81
Article tone
informal
Language
English
Language complexity
34
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links
